Keyword: Johnson & Johnson
News
20.02.2014
- German pharmaceutical producer Boehringer Ingelheim is being confronted in the U.S. with more than 2,000 lawsuits related to its blood thinner Pradaxa (dabigatran). The plaintiffs...
News
17.01.2014
- As expected, U.S. private equity investor Carlyle has been given the nod to acquire the ortho clinical diagnostics unit of compatriot pharmaceutical producer Johnson & Johnson (J&J...
News
10.01.2014
- Johnson & Johnson on Wednesday said it submitted a citizen petition asking that U.S. health regulators require copies of biological products to bear names that are similar and not...
News
06.01.2014
- Private equity investor Carlyle is in exclusive talks to buy Johnson & Johnson's ortho clinical diagnostics unit for around $4 billion, after knocking Blackstone out of the race...
News
13.12.2013
- The European Commission has fined U.S. pharmaceutical producer Johnson & Johnson (J&J) €10.8 million and Swiss drugmaker Novartis of Switzerland € 5.5 million for actions taken by...
News
13.11.2013
- Johnson & Johnson will pay more than $4 billion to settle thousands of lawsuits over its recalled defective hip implants, Bloomberg reported late on Tuesday, citing three people...
News
28.08.2013
- Johnson & Johnson said on Tuesday the business heads of its three Chinese operations would begin to report to one local chairman next month in an effort to increase sales and...
News
23.08.2013
- Onyx Pharmaceuticals has given potential buyers, including Amgen, access to trial data on its new cancer drug, removing a key hurdle that was holding up deal talks, according to...
